Acinetobacter seifertii is a recently described species that belongs to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. It has been recovered from clinical samples and is sometimes associated with antimicrobial resistance determinants. We present here the case of three A. seifertii clinical isolates which were initially identified as Acinetobacter sp. by phenotypic methods but no identification at the species level was achieved using semi-automated identification methods. The isolates were further analysed by whole genome sequencing and identified as A. seifertii. Due to the fact that A. seifertii has been isolated from serious infections such as respiratory tract and bloodstream infections, we emphasize the importance of correctly identifying isolates of the genus Acinetobacter at the species level to gain a deeper knowledge of their prevalence and clinical impact.
Acinetobacter seifertii is one of the most recently named members of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex [1] . The first two strains of this species were isolated from human clinical specimens (ulcer and blood) in Denmark in 1990-1991 [1, 2] . A. seifertii has since been found in diverse clinical samples worldwide, and it has also been isolated from environmental samples both inside and outside of the hospital [1, 3] . Although the clinical relevance of A. seifertii seems to be lower than that of other members of the complex, reports of its incidence causing infections have been published recently [4, 5] and according to previous studies, Acinetobacter species can be a predictive factor for mortality and should be included in the analysis of risk factors; it can also be used as a predictor for the outcome of Acinetobacter species bacteremia [6] . In addition, some isolates were shown to have acquired antimicrobial resistance genes such as the plasmid-encoded carbapenemase bla OXA-58 , and bla OXA-51 which is intrinsic to A. baumannii, and can therefore make anti-infective therapy difficult [5, 7] .
Correct species identification of bacteria of the A. calcoaceticus-A. baumannii complex using common metabolic tests or commercial phenotypic systems in diagnostic laboratories is not always possible, owing to their limited ability to distinguish between the different members of the complex [4, 5] . In addition, the databases of the currently used mass spectrometry technology (Bruker MALDI Biotyper and bio-M erieux VITEK MS) presently do not include A. seifertii and other more recently described Acinetobacter spp. More accurate identification of Acinetobacter species requires molecular techniques such as gyrB multiplex PCR [8] or rpoB sequencing [1, 4, 9] . The most reliable identification approaches include MLSA (multi locus sequence analysis) and the comparison of whole genome sequences [1] . Here we present the case of three A. seifertii clinical isolates from two Bolivian hospitals, which were initially grouped as Acinetobacter spp.
In three patients admitted to two different hospitals in the city of Cochabamba, Bolivia, three isolates were recovered and identified as Acinetobacter sp. using phenotypical methods by the hospital laboratories according to the following criteria: Gram-negative by Gram stain; non-fermenter (K/K) by triple sugar iron agar; negative motility in brain heart infusion broth; negative oxidase; negative gelatin liquefaction and negative haemolysis; it was assumed that the isolates were A. baumannii and patients were managed accordingly. The first isolate was recovered from a pressure ulcer (isolate V1371) in a 33-year-old man from Hospital A in February 2016. The other two isolates were obtained from Hospital B in March and April 2016, respectively. The first patient was a 59-year-old woman with an intra-abdominal abscess from which the sample was taken (isolate MI30-324), the other isolate was recovered from a catheter in a 2-year-old child diagnosed with sepsis (isolate MI421-133). Isolates were forwarded to the University of the Basque Country, Bilbao, Spain, for further analysis.
MICs of imipenem, meropenem, ciprofloxacin, tigecycline and gentamicin were determined by agar dilution and MIC for colistin was determined by broth microdilution following the EUCAST guidelines and breakpoints (www.eucast. org/clinical_breakpoints/) [10] . All three isolates were susceptible to ciprofloxacin (MICs: 0.5-1 µg ml portioned matrix were used for species identification. Semiautomated identification using the VITEK2 GN ID card was only able to assign the isolates to the A. baumannii complex (containing also Acinetobacter pittii and Acinetobacter nosocomialis) and MALDI-TOF MS (Bruker MALDI Biotyper, HCCA portioned matrix) results showed a mixed pattern of A. baumannii (scores ranging from 2.02 to 2.34) and A. pittii (scores ranging from 1.89 to 2.08) ( Table 1) .
gyrB and bla OXA multiplex PCRs were used for species identification and evaluation of intrinsic and acquired carbapenemase genes [8, [11] [12] [13] . The band patterns obtained by gyrB multiplex PCR were inconclusive as well, they included bands specific for both A. pittii and A. baumannii. No bla OXA genes were detected including the bla OXA-51-like which is intrinsic to A. baumannii (Table 1) , however the detection of the bla OXA-51-like on its own is not reliable enough to identify A. baumannii and in addition to this, other Acinetobacter spp. have acquired this gene [7, 14] .
Because no conclusive results were obtained by these methods, whole genome sequencing was performed for the identification at the species level. Nextera XT library prep kit (Illumina GmbH, Germany) was used to prepare the sequencing libraries for a 250 bp paired-end sequencing run on an Illumina MiSeq sequencer. The FASTQ files containing paired reads were de novo assembled with Velvet assembler (Ridom SeqSphere+ v.3.0 software).
The CGE web-tools SpeciesFinder 1.2, based on the complete 16 s rRNA gene for species identification, and KmerFinder 2.0 were used (https://cge.cbs.dtu.dk/services/). SpeciesFinder failed to resolve the species identification and A. baumannii was the first hit using KmerFinder, which we considered as a non-valid result because no bla OXA-51-like gene was found in any of the three isolates (Table 1) . Partial rpoB sequence was also analysed for species identification by using the online tool leBIBI-QBPP (https://umr5558-bibiserv.univ-lyon1.fr/lebibi/lebibi.cgi) with the rpoB stringent bacteria database [1, 9] . Partial rpoB analysis clustered the isolates with A. seifertii, therefore further analysis of the three isolates was carried out.
MLSA using CLUSTALW2 was performed; the concatenated sequences of the seven housekeeping genes used for the Pasteur MLST scheme were compared to those of 43 reference strains (seven A. calcoaceticus, 18 A. baumannii, six A. nosocomialis, 10 A. pittii, two Acinetobacter genomic species 'between 1 and 3') and 15 A. seifertii strains used by Nemec et al. to describe the species [1] . MLSA revealed that the percentage of similarity within species was above 97.8 % while interspecies similarity was below 97.0 %. The highest similarity values obtained positioned the three isolates together with A. seifertii (Table 1) , showing similar values to those obtained in a previous study [1] . Furthermore, a neighbour-joining tree was constructed based on the seven concatenated housekeeping genes of the Pasteur scheme (MI30-324, ST994; MI421-133, ST994 and V1371, ST1064) and the three isolates fell within the cluster of A. seifertii strains.
The digital DNA-DNA hybridization (dDDH) parameter was calculated between the genome sequences of the three studied isolates and the type strains of the validly named species of the complex (A. A. seifertii NIPH 973 T ) using the GGDC 2.1 (http://ggdc. dsmz.de) program, with the recommended parameters and threshold value for species at 70 % [15] . In addition, JSpeciesWS webserver (http://jspecies.ribohost.com/jspeciesws/) was used to determine the average nucleotide identity based on BLAST+ (ANIb) for species identification using the same set of complete genomes. A cut-off at 95 % was used [16] . Additionally, dDDH results were congruent with MLSA, showing values above 70 % between the three studied isolates and A. seifertii NIPH 973 T (Table 2) . ANIb also supported these results as all three isolates had values well above the 95 % for A. seifertii (Table 2 ). Isolates MI30-324 and MI421-133 presented highly similar genomes as determined by ANIb and dDDH values, 99.9 and 100 % respectively; such values classify these isolates as belonging to the same strain. Of note, these isolates did not have any obvious temporal or spatial relation, the patients could have been infected by a common source or due to an intrahospital spread.
The whole genome shotgun projects for A. seifertii MI30-324, MI421-133 and V1371 have been deposited at DDBJ/ ENA/GenBank under the accession numbers PGPD00000000, PHFF00000000 and PHFG00000000, respectively. The versions described in this paper are PGPD00000000.1, PHFF00000000.1 and PHFG00000000.1.
While A. baumannii remains the most frequently recovered species of the genus Acinetobacter from clinical samples, there are increasing reports of other Acinetobacter species being involved in human infections [4, 5] . To the best of our knowledge, this is the first report of A. seifertii in Bolivia causing different infections and the second report from South America [5] .
A. seifertii infections and their outcomes are not well characterized yet, nonetheless in vitro virulence-associated phenotypes such as increased biofilm formation, cell adherence and resistance to human serum were found in Korean isolates [17] . Both cell adherence and biofilm formation could have contributed to the catheter-related infection, ulcer infection and abscess formation.
Although A. seifertii has now been reported to cause serious infections, it is in general susceptible to antimicrobials [4] but in some cases, plasmids carrying antimicrobial resistance genes have been described within this species [5, 7] . The acquisition of different antimicrobial resistance determinants is worrying because it narrows the therapeutic options. Furthermore, having the correct Acinetobacter species identification is important to understand the epidemiology and the clinical impact of the various Acinetobacter species since the clinical outcomes can be very diverse among the different Acinetobacter species [6, 18] . In our case, the standard tests used for species identification in the diagnostic laboratories were not successful, reflecting that newer species such as A. seifertii are not yet included in the databases of these semi-automated identification methods, furthermore, the necessity to include them in the Bruker taxonomy database has been already discussed [18] . Moreover, the limitations of using VITEK2 and also rpoB sequences for identification of Acinetobacter spp. have already been described [9, 19] and under-reporting of A. seifertii and other Acinetobacter species may be occurring due to the difficulties to identify them. As already stated by Khosravi et al., identification based on a single gene sequence may not always be fully reliable [9] , in addition, a former study was not able to identify eleven Acinetobacter spp. isolates to the species level by using partial rpoB sequencing [19] . Although rpoB sequence analysis revealed A. seifertii as the species, further analysis was carried out.
Nowadays, the most reliable methods for bacterial identification are based on the whole genome sequence [1, 20, 21] , and our results based on these methods were congruent and allowed us to identify the species of the three isolates. Since whole genome sequencing is not available in all laboratories, partial rpoB sequencing could be an alternative tool to identify those cases in which the identification to the species level was not achieved by other routine methods [1] .
In conclusion, the phenotypic methods did not work for A. seifertii identification and neither did the semiautomated identification methods since A. seifertii is not included in the databases of these systems. In this study, identification of the three isolates to the species level was not possible until a genomic approach was performed.
A. seifertii appears to be a challenge as various studies have described misidentification of this species. To the best of our knowledge, this is the first report of A. seifertii isolates in Bolivia and even if its prevalence, epidemiology or virulence are not yet well known, an improvement in diagnostic laboratories should be made in order to include this organism of growing importance since it might be a potential emerging human pathogen. Further studies should be carried forward in order to better characterize this species and analyse its incidence and clinical impact.
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